ASTM E2525-2008 Standard Test Method for Evaluation of the Effect of Nanoparticulate Materials on the Formation of Mouse Granulocyte-Macrophage Colonies《评定纳米粒子材料费对老鼠粒细胞巨噬细胞集落形成影响的标.pdf

《ASTM E2525-2008 Standard Test Method for Evaluation of the Effect of Nanoparticulate Materials on the Formation of Mouse Granulocyte-Macrophage Colonies《评定纳米粒子材料费对老鼠粒细胞巨噬细胞集落形成影响的标.pdf》由会员分享，可在线阅读，更多相关《ASTM E2525-2008 Standard Test Method for Evaluation of the Effect of Nanoparticulate Materials on the Formation of Mouse Granulocyte-Macrophage Colonies《评定纳米粒子材料费对老鼠粒细胞巨噬细胞集落形成影响的标.pdf（5页珍藏版）》请在麦多课文档分享上搜索。

1、Designation: E 2525 08Standard Test Method forEvaluation of the Effect of Nanoparticulate Materials on theFormation of Mouse Granulocyte-Macrophage Colonies1This standard is issued under the fixed designation E 2525; the number immediately following the designation indicates the year oforiginal adop

2、tion or, in the case of revision, the year of last revision. A number in parentheses indicates the year of last reapproval. Asuperscript epsilon (e) indicates an editorial change since the last revision or reapproval.1. Scope1.1 This test method provides a protocol for quantitativeanalysis of the ef

3、fect of nanoparticulate materials in physi-ologic solution on granulocyte-macrophage colony-formingunits.1.2 This test method employs murine bone marrow hemato-poietic stem cells which proliferate and differentiate to formdiscrete cell clusters or colonies which are counted.1.3 This test method is p

4、art of the in vitro preclinicalcharacterization cascade for nanoparticulate materials for sys-temic administration in medical applications.1.4 This standard does not purport to address all of thesafety concerns, if any, associated with its use. It is theresponsibility of the user of this standard to

5、 establish appro-priate safety and health practices and determine the applica-bility of regulatory limitations prior to use.2. Referenced Documents2.1 ASTM Standards:2F 1903 Practice for Testing For Biological Responses toParticles in vitro2.2 ANSI Standard:ANSI/ AAMI ST72 Bacterial EndotoxinsTest M

6、ethod-ologies, Routine Monitoring, and Alternatives to BatchTesting33. Terminology3.1 Abbreviations:3.1.1 BMbone marrow3.1.2 CFU-GMcolony forming unit of granulocyte andmacrophage3.1.3 Cisplatinpositive control3.1.4 DMSOdimethyl sulfoxide3.1.5 DPBSDulbeccos phosphate buffered saline3.1.6 FBSfetal bo

7、vine serum3.1.7 IMDMIscoves media3.1.8 LPSipopolysaccharide3.1.9 Physiologic Solutionisotonic, pH 7.2 6 0.24. Summary of Test Method4.1 The effect of nanoparticulate materials on the formationof granulocyte and macrophage colonies is assessed. Bonemarrow cells are obtained from mice and cultured in

8、stimula-tory media. The number of colony forming units followingcontact with nanoparticles is counted and compared to baselineand positive control. This determines if the nanoparticulatematerial in physiologic solution is stimulatory or inhibitory tobone marrow stem cells. Aseptic procedures are nec

9、essary.5. Significance and Use5.1 Stem cells of hematopoietic origin are pluripotential andmay be particularly sensitive to the effects of stimulation bynanoparticulate materials.5.2 The effect of particles on macrophage responses has anextensive history and can be assessed by Practice F 1903. Thete

10、st method described here will assess the effect on stem cellswhich can be progenitor cells to the macrophage line.6. Reagents and Materials6.1 Purity of ReagentsReagent grade chemicals shall beused in all tests. Unless otherwise indicated, it is intended thatall reagents conform to the specification

11、s of the Committee onAnalytical Reagents of the American Chemical Society wheresuch specifications are available.4Other grades may be used,provided it is first ascertained that the reagent is of sufficientlyhigh purity to permit its use without lessening the accuracy ofthe determination.6.2 Reagents

12、 and Supplies:6.2.1 MethoCult medium, StemCell Technologies Inc cat.#03534.1This test method is under the jurisdiction of ASTM Committee E56 onNanotechnology and is the direct responsibility of Subcommittee E56.02 onCharacterization: Physical, Chemical, and Toxicological Properties.Current edition a

13、pproved Feb. 1, 2008. Published February 2008.2For referenced ASTM standards, visit the ASTM website, www.astm.org, orcontact ASTM Customer Service at serviceastm.org. For Annual Book of ASTMStandards volume information, refer to the standards Document Summary page onthe ASTM website.3Available from

14、 American National Standards Institute (ANSI), 25 W. 43rd St.,4th Floor, New York, NY 10036, http:/www.ansi.org.4Reagent Chemicals, American Chemical Society Specifications, AmericanChemical Society, Washington, DC. For Suggestions on the testing of reagents notlisted by the American Chemical Societ

15、y, see Analar Standards for LaboratoryChemicals, BDH Ltd., Poole, Dorset, U.K., and the United States Pharmacopeiaand National Formulary, U.S. Pharmacopeial Convention, Inc. (USPC), Rockville,MD.1Copyright ASTM International, 100 Barr Harbor Drive, PO Box C700, West Conshohocken, PA 19428-2959, Unit

16、ed States.6.2.2 Fetal Bovine Serum prescreened for hematopoieticstem cells, StemCell Technologies Inc cat.# 06200.6.2.3 IMDM with 2 % FBS, StemCell Technologies Inccat.# 07700.6.2.4 Sterile distilled water.6.2.5 Cisplatin, (positive control) Sigma cat# P4394.6.2.6 Sterile Ca2+/MG2+-free DPBS, (negat

17、ive control)Sigma cat.# D8537.NOTE 1The source of the reagents is shown for information purposesonly to aid laboratories initiating this procedure. Equivalent reagents fromother suppliers may be used.6.3 EquipmentAseptic procedures are necessary and careshould be used in acquiring sterile equipment

18、as needed.6.3.1 Pipettes covering the range of 0.05 to 10 mL.6.3.2 35-mm culture dishes prescreened to support stem cellgrowth and differentiation, StemCell Technologies Inc cat.#27100.6.3.3 Blunt-end 16-gauge needles, StemCell TechnologiesInc cat.# 03534.6.3.4 100-mm Petri dishes.6.3.5 Plastic beak

19、ers.6.3.6 Polypropylene tubes 50 and 15-mL.6.3.7 Centrifuge.6.3.8 Refrigerator, 2 to 8C.6.3.9 Freezer, 20C.6.3.10 Cell culture incubator with 5 % CO2and 95 %humidity.6.3.11 CO2euthanasia box, or appropriate equipment ap-proved by institution.6.3.12 Scissors for tissue dissection.6.3.13 Forceps.6.3.1

20、4 Biohazard safety cabinet approved for level II han-dling of biological material.6.3.15 Inverted microscope.6.3.16 Vortex.6.3.17 Hemocytometer.6.4 AnimalsMice of the strain C56BL/6, males or females8 to 12 weeks old, are used. Use of the pooled cells derivedfrom at least two (2) animals is highly r

21、ecommended.7. Procedure7.1 Aseptic Precautions are required.7.2 Reagent and Control Preparation:7.2.1 MethoCult MediumThe MethoCult medium is sup-plied in 100-mL size batches. It is recommended by manufac-turer that the medium be thawed at room temperature or in arefrigerator overnight, vortexed to

22、mix the ingredients, then leftat a room temperature for approximately 5 min to allow airbubbles to dissipate. If using another source of media, followthe instructions indicated by the supplier. Use a 16-gaugeblunt-end needle to dispense 3-mL aliquots of the MethoCultmedium into sterile 15-mL tubes.

23、Store the aliquoted mediumat a nominal temperature of 20C. Before the test thaw therequired number of tubes at room temperature for approxi-mately 20 min and keep on ice prior to use. Repeated freezingand thawing should be avoided.7.2.2 50 mM Cisplatin (Positive Control)Cisplatin issupplied in a lyo

24、philized form. Reconstitute the lyophilizedpowder by adding the appropriate amount of DMSO to make astock solution with nominal concentration of 50 mM. Preparesmall aliquots and store at a nominal temperature of 80 C.Prior to use in the assay, thaw an aliquot of the stock solutionat room temperature

25、 and dilute in IMDM supplemented with2 % FBS to bring the Cisplatin concentration to 2 mM. Onehundred fifty (150) L of this intermediate solution is thenadded to 3 mL of culture medium. Final concentration ofCisplatin in the positive control sample is 100 M.7.3 Preparation of Study Samples:7.3.1 Thi

26、s assay requires 1200 L of nanoparticles, 150 Lsamples in duplicate for each of 4 concentrations. The nano-particles subjected to the biological test environment shouldhave been characterized as appropriate to allow adequate datainterpretation and to help provide information to predictbiological res

27、ponses. For example, lot-to-lot variations inparticle size and surface characteristics of the particles couldresult in different assay results. For this assay, the particlesshall be provided in physiologic solution (isotonic with pH7.2 6 0.2) and this solution shall be defined. The preparationshall

28、be sterile and the level of LPS provided or determined bythe testing laboratory. ANSI/AAMI ST72 may be helpful. Thenumber of particles/mL and mg/mL shall be indicated.7.3.2 The test sample shall be used at the highest concen-tration possible and at three serial one to five (1:5) dilutions.The highes

29、t possible concentration is that at which the particlesappear evenly dispersed in the liquid. If the concentration forits intended use is known, this may serve as the highestconcentration to be tested and at least three dilutions made.7.4 Isolation and Counting of Bone Marrow Cells:7.4.1 Position th

30、e euthanized mouse on its back and rinsefur thoroughly with 70 % alcohol.7.4.2 Cut a slit in the fur just below the rib cage withoutcutting the peritoneal membrane.7.4.3 Firmly grasp skin and peal back to expose hind limbs.7.4.4 Using sterile sharp dissecting scissors cut the kneejoint in the center

31、. Cut through ligaments and excess tissue.7.4.5 Grasp femur with forceps and cut femur near hip joint.7.4.6 Free tibia by cutting near the ankle joint.7.4.7 Trim the ends of the long bones to expose the interiormarrow shaft. Put bones in a sterile Petri dish or in sterileculture medium and place on

32、ice. Bones should be collectedfrom multiple animals.7.4.8 Using a 3-cc syringe with 21 or 22-gauge needle, drawup to 1 to 3 mL of cold Iscoves MDM supplemented with 2 %FBS.7.4.9 Insert bevel of needle into marrow shaft and flushmarrow into 15-mL tube. Repeat this procedure for all bones.The same med

33、ium can be used to isolate marrow from 1 to 3animals. The medullary canal should appear white once all themarrow has been expelled.7.4.10 Keep the needle below the surface of the medium andgently draw the cell suspension up and down with 3-cc syringeand 21-gauge needle 3 to 4 times to make a single

34、cellsuspension without introducing air bubbles.7.4.11 Keep cells in medium on ice until use.7.4.12 Perform a nucleated cell count. Dilute an aliquotsample of the cells with 3 % acetic acid with methylene blueE25250821:50 (20 L cells + 980 L 3 % acetic acid methylene blue) or1:100 (10 L cells + 990 L

35、 3 % acetic acid methylene blue).Then use either hemocytometer or automatic cell counter (thatcounts nucleated live cells) to determine the number of viablenucleated cells. An average cell count is expected to be12 3 107for femur and 0.61 3 107for tibia from eachmouse.7.4.13 If cell viability and co

36、unt are acceptable providing atleast 106viable cells proceed to the next step.7.5 Experimental Procedure:7.5.1 Label lids of 35-mm culture dishes at the edge using apermanent fine felt marker. There will be two 35-mm culturedishes for each control and test article.7.5.2 Thaw the aliquoted tubes of M

37、ethoCult medium atroom temperature or in a refrigerator overnight.7.5.3 Vortex tubes to ensure all components are thoroughlymixed.7.5.4 Dilute bone marrow cells isolated according to theprocedure described in section 6 with Iscoves medium supple-mented with 2 % FBS to 4 3 105cells per mL.7.5.5 Add 1

38、50 L of cell suspension and 150 L of eitherIscoves medium with 2 % FBS (baseline), PBS (negativecontrol), Cisplatin (positive control), or nanoparticles (testsample) to 3 mL of MethoCult medium.7.5.6 Vortex tubes to ensure all cells and medium compo-nents are mixed thoroughly.7.5.7 Let the tubes sta

39、nd for 5 min to allow bubbles todissipate.7.5.8 Label two 35-mm Petri dishes for each sample:baseline, negative control, positive control, and the test articles.Each sample is thus tested in duplicate.7.5.9 Attach a 16-gauge blunt-ended needle to a 3-ccsyringe, place the needle below the surface of

40、the solutionprepared in 7.5.5. Draw up approximately 1 mL, then gentlydepress the plunger and expel medium back into the tube.Repeat this step until no air space is visible.7.5.10 With this syringe and needle, draw up the solutionand dispense 1.1 mL into each of two 35-mm dishes. Distributethe cell

41、suspension evenly by gently tilting and rotating eachdish. Cover the 35-mm dishes and place the two replicates intoa 100-mm Petri dish. Place a third 35-mm dish into the100-mm Petri dish and fill this 35-mm dish with 3 mL of sterilewater and do no cover this dish. This will provide a humiditychamber

42、. Place the lid on the 100-mm Petri dish.7.5.11 Repeat 7.5.10 for all samples and place the culturesin an incubator maintained at 37C, 5 % CO2and 95 %humidity.7.5.12 Incubate for 12 days. On the 12th day remove dishesfrom incubator, identify and count colonies as described below.Representative value

43、s of CFU-GM for C57BL6 mice at 8 to 12weeks of age range from 64 6 16.7.6 Count the CFU-GM Colonies:7.6.1 This count includes the CFU-granulocyte (CFU-G),CFU-macrophage (CFU-M) and CFU-granulocyte macroph-age (CFU-GM). Count the colonies containing at least 30CFU-G, CFU-M or both cell types (CFU-GM)

44、. CFU-GMcolonies often contain multiple clusters and appear as densecore surrounded by cells. The monocytic lineage cells are largecells with an oval to round shape and appear to have a grainyor grey center. The granulocytic lineage cells are round, bright,and are much smaller and more uniform in si

45、ze than macroph-ages. It is easy to see individual cells of a CFU-GM colony,especially in the periphery of the colony.7.6.2 See Fig. 1 for the following colony examples. Colo-nies seen on Figures A and B are CFU-GM. Colonies onFigures C and D are CFU-M. Figure E demonstrates anexample of single CFU-

46、G colony. Few CFU-G coloniesgrowing together are shown on Figure F.8. Calculation or Interpretation of Results8.1 Determine the mean and standard deviation and thePercent Coefficient of Variation for each control or testaccording to the following formula:%CV 5 SD/Mean 3 100 % (1)8.2 Percent CFU Inhi

47、bition is calculated as follows:% CFU2Inhibition 5Baseline CFU2GM Test CFU2GM!Baseline CFU2GM3 100 %(2)9. Report9.1 %CV for each control and test sample should less than30 %.9.1.1 If the positive control or negative control fail to meetacceptance criterion described in 9.1 the assay should berepeate

48、d.9.1.2 If the assay meets the acceptable criteria but a testsample fails to meet acceptance criterion described in 9.1 thistest sample should be re-analyzed.9.1.3 If two duplicates of the same test sample demonstrateresults different by more then 20 %, this sample should bereanalyzed.9.1.4 Determin

49、e if the results of the test sample are differentfrom the media control and indicate if the test sample isstimulatory or inhibitory.9.1.5 Determine if there is a dose response.10. Precision and Bias10.1 Precision and bias have not been determined for thistest method and will be determined within 5 years of publica-tion of the standard. At this time there is no commerciallyavailable test article of sufficient quantity and reproduciblequality to conduct intra- or interlaboratory comparisons ofprecision and bias.11. Keywords11.1 bone marrow; CFU